These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19887580)

  • 41. Osteoblast-targeted overexpression of TAZ increases bone mass in vivo.
    Yang JY; Cho SW; An JH; Jung JY; Kim SW; Kim SY; Kim JE; Shin CS
    PLoS One; 2013; 8(2):e56585. PubMed ID: 23441207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption.
    Yeo H; Beck LH; Thompson SR; Farach-Carson MC; McDonald JM; Clemens TL; Zayzafoon M
    J Biol Chem; 2007 Nov; 282(48):35318-27. PubMed ID: 17884821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activity of the osteocalcin promoter in skeletal sites of transgenic mice and during osteoblast differentiation in bone marrow-derived stromal cell cultures: effects of age and sex.
    Frenkel B; Capparelli C; Van Auken M; Baran D; Bryan J; Stein JL; Stein GS; Lian JB
    Endocrinology; 1997 May; 138(5):2109-16. PubMed ID: 9112411
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TIEG1 enhances Osterix expression and mediates its induction by TGFβ and BMP2 in osteoblasts.
    Subramaniam M; Pitel KS; Withers SG; Drissi H; Hawse JR
    Biochem Biophys Res Commun; 2016 Feb; 470(3):528-533. PubMed ID: 26801561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transgenic models of metabolic bone disease: impact of estrogen receptor deficiency on skeletal metabolism.
    McCauley LK; Tözüm TF; Kozloff KM; Koh-Paige AJ; Chen C; Demashkieh M; Cronovich H; Richard V; Keller ET; Rosol TJ; Goldstein SA
    Connect Tissue Res; 2003; 44 Suppl 1():250-63. PubMed ID: 12952206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conditional disruption of IGF-I gene in type 1α collagen-expressing cells shows an essential role of IGF-I in skeletal anabolic response to loading.
    Kesavan C; Wergedal JE; Lau KH; Mohan S
    Am J Physiol Endocrinol Metab; 2011 Dec; 301(6):E1191-7. PubMed ID: 21878662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NFI-C regulates osteoblast differentiation via control of osterix expression.
    Lee DS; Choung HW; Kim HJ; Gronostajski RM; Yang YI; Ryoo HM; Lee ZH; Kim HH; Cho ES; Park JC
    Stem Cells; 2014 Sep; 32(9):2467-79. PubMed ID: 24801901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cathepsin S controls adipocytic and osteoblastic differentiation, bone turnover, and bone microarchitecture.
    Rauner M; Föger-Samwald U; Kurz MF; Brünner-Kubath C; Schamall D; Kapfenberger A; Varga P; Kudlacek S; Wutzl A; Höger H; Zysset PK; Shi GP; Hofbauer LC; Sipos W; Pietschmann P
    Bone; 2014 Jul; 64():281-7. PubMed ID: 24780878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective osteoblast overexpression of IGF-I in mice prevents low protein-induced deterioration of bone strength and material level properties.
    Brennan-Speranza TC; Rizzoli R; Kream BE; Rosen C; Ammann P
    Bone; 2011 Nov; 49(5):1073-9. PubMed ID: 21840432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation.
    Zhao G; Monier-Faugere MC; Langub MC; Geng Z; Nakayama T; Pike JW; Chernausek SD; Rosen CJ; Donahue LR; Malluche HH; Fagin JA; Clemens TL
    Endocrinology; 2000 Jul; 141(7):2674-82. PubMed ID: 10875273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass.
    Geoffroy V; Marty-Morieux C; Le Goupil N; Clement-Lacroix P; Terraz C; Frain M; Roux S; Rossert J; de Vernejoul MC
    J Bone Miner Res; 2004 May; 19(5):811-22. PubMed ID: 15068505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early B-cell Factor1 (Ebf1) promotes early osteoblast differentiation but suppresses osteoblast function.
    Nieminen-Pihala V; Tarkkonen K; Laine J; Rummukainen P; Saastamoinen L; Nagano K; Baron R; Kiviranta R
    Bone; 2021 May; 146():115884. PubMed ID: 33582307
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cdc42 in osterix-expressing cells alters osteoblast behavior and myeloid lineage commitment.
    Wirth F; Huck K; Lubosch A; Zoeller C; Ghura H; Porubsky S; Nakchbandi IA
    Bone; 2021 Dec; 153():116150. PubMed ID: 34400384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties.
    Wang CJ; Chen IP; Koczon-Jaremko B; Boskey AL; Ueki Y; Kuhn L; Reichenberger EJ
    Bone; 2010 May; 46(5):1306-15. PubMed ID: 20117257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p53 deficiency promotes bone regeneration by functional regulation of mesenchymal stromal cells and osteoblasts.
    Nagashima T; Ninomiya T; Nakamura Y; Nishimura S; Ohashi A; Aoki J; Mizoguchi T; Tonogi M; Takahashi T
    J Bone Miner Metab; 2022 May; 40(3):434-447. PubMed ID: 35195777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ephrin B1 regulates bone marrow stromal cell differentiation and bone formation by influencing TAZ transactivation via complex formation with NHERF1.
    Xing W; Kim J; Wergedal J; Chen ST; Mohan S
    Mol Cell Biol; 2010 Feb; 30(3):711-21. PubMed ID: 19995908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mesenchymal Deletion of Histone Demethylase NO66 in Mice Promotes Bone Formation.
    Chen Q; Sinha K; Deng JM; Yasuda H; Krahe R; Behringer RR; de Crombrugghe B
    J Bone Miner Res; 2015 Sep; 30(9):1608-17. PubMed ID: 25736226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PAPP-A2 expression by osteoblasts is required for normal postnatal growth in mice.
    Amiri N; Christians JK
    Growth Horm IGF Res; 2015 Dec; 25(6):274-80. PubMed ID: 26385171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancer of zeste homolog 2 (
    Dudakovic A; Camilleri ET; Paradise CR; Samsonraj RM; Gluscevic M; Paggi CA; Begun DL; Khani F; Pichurin O; Ahmed FS; Elsayed R; Elsalanty M; McGee-Lawrence ME; Karperien M; Riester SM; Thaler R; Westendorf JJ; van Wijnen AJ
    J Biol Chem; 2018 Aug; 293(33):12894-12907. PubMed ID: 29899112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osteoblast/osteocyte-specific inactivation of Stat3 decreases load-driven bone formation and accumulates reactive oxygen species.
    Zhou H; Newnum AB; Martin JR; Li P; Nelson MT; Moh A; Fu XY; Yokota H; Li J
    Bone; 2011 Sep; 49(3):404-11. PubMed ID: 21555004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.